Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

PHASE3CompletedINTERVENTIONAL
Enrollment

4,514

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Influenza, Human
Interventions
BIOLOGICAL

QIVc

Cell-derived Quadrivalent Influenza Vaccine for intramuscular use containing each of the 2 influenza type A strains and each of the 2 influenza type B strains

BIOLOGICAL

Non-influenza Comparator Vaccine

Non-influenza comparator vaccine for intramuscular use

Trial Locations (40)

1000

403 Philippine General Hospital, Manila

404 Philippine General Hospital, Manila

1781

400 Research Institute For Tropical Medicine, Muntinlupa

401 Research Institute For Tropical Medicine, Muntinlupa

406 Research Institute For Tropical Medicine, Muntinlupa

3010

300 Murdoch Childrens Research Institute, Carlton

4075

302 AusTrials Pty Ltd, Sherwood

4114

402 De La Salle Health Sciences Institute, Dasmariñas

405 De La Salle Health Sciences Institute, Dasmariñas

10617

500 Merelahe Family Doctors Centre, Tallinn

504 Merekivi Family Doctors Ltd, Tallinn

13619

502 Medicum AS, Tallinn

15706

900 Complejo Hospitalario Universitario de Santiago, Santiago de Compostela

40002

200 Srinagarind Hospital, Khon Kaen University, Khon Kaen

47116

704 Kauno klinikine ligonine, Kaunas

48259

703 UAB InMedica, Kaunas

700 Kaunas Silainiai Outpatient Clinic, Kaunas

49449

702 JSC Saules seimos medicinos centras, Kaunas

50106

505 Clinical Research Center, Tartu

50200

201 ChiangMai University, Chiang Mai

62142

706 Private Office of Children Pulmonologist, Alytus

67100

606 Kokkola Vaccine Research Clinic, Kokkola

72713

503 Vee Family Doctors Centre, Paide

Unknown

505 Clinical Research Center, Tartu

607 Espoo Vaccine Research Clinic, Espoo

603 Helsinki South Vaccine Research Clinic, Helsinki

604 Helsinki South Vaccine Research Clinic, Helsinki

600 Järvenpää Vaccine Research Clinic, Järvenpää

605 Oulu Vaccine Research Clinic, Oulu

601 Pori Vaccine Research Clinic, Pori

602 Seinäjoki Vaccine Research Clinic, Seinäjoki

608 Tampere Vaccine Research Clinic, Tampere

609 Turku Vaccine Research Clinic, Turku

02169

701 Naujininkai Outpatient Clinic, Vilnius

85-168

805 Szpital Uniwersytecki nr 2 im. dr. Jana Biziela w Bydgoszczy, Bydgoszcz

33-100

806 Specjalistyczny Szpital im. E. Szczeklika w Tarnowie, Tarnów

55-100

803 Szpital im. Sw. Jadwigi Slaskiej w Trzebnicy, Trzebnica

21-010

"800 Niepubliczny Zaklad Opieki Zdrowotnej (NZOZ) Salmed s. c.", Łęczna

39-200

804 Prywatny Gabinet Lekarski, Dębica

41-103

NZLA Michalkowice - Jarosz i Partnerzy Spolka Lekarska, Siemianowice Śląskie

All Listed Sponsors
lead

Seqirus

INDUSTRY

NCT03165617 - Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age | Biotech Hunter | Biotech Hunter